Israel Medical Association Journal最新文献_第10页

Reduction in Time from Admission to Operation of Women with Suspected Adnexal Torsion During the COVID-19 Pandemic. 在 COVID-19 大流行期间，疑似附件扭转的妇女从入院到手术时间的缩短。

IF 1.8 4区医学

Israel Medical Association Journal Pub Date : 2024-08-01

Nir Meller, Gabriel Levin, Adiel Cohen, Aya Mohr-Sasson, Hadar Lahav, Shlomo B Cohen, Roy Mashiach, Raanan Meyer

{"title":"Reduction in Time from Admission to Operation of Women with Suspected Adnexal Torsion During the COVID-19 Pandemic.","authors":"Nir Meller, Gabriel Levin, Adiel Cohen, Aya Mohr-Sasson, Hadar Lahav, Shlomo B Cohen, Roy Mashiach, Raanan Meyer","doi":"","DOIUrl":"","url":null,"abstract":"Background: Data regarding the management of adnexal torsion (AT) during the coronavirus disease 2019 (COVID-19) pandemic are scarce.Objectives: To study the effects of actions to limit the spread of COVID-19 on AT management.Methods: We conducted a retrospective cohort study of all women who underwent laparoscopy for suspected AT between March 2011 and February 2021. We compared the COVID-19 pandemic period, (15 March 2020-2 August 2021, group A) to a parallel period (2019-2020, group B), and a 9-year period preceding the pandemic (March 2011-February 2020, group C).Results: We performed 97 laparoscopies in group A, 82 in group B, and 635 in group C. The proportion of women presenting following in vitro fertilization treatment was lower (odds ratio [OR] 0.22, 95% confidence interval ]95%CI] (0.06-0.86), P < 0.023). Time from admission to decision to operate was shorter (2.7 vs. 3.9 hours, P = 0.028) in group A than group B. Time from admission to surgery was shorter (9.1 vs. 12.5 hours, P = 0.005) and the rate of surgically confirmed AT was lower (59 [60.8%] vs. 455 [71.7%], P = 0.030, OR 0.61, 95%CI 0.39-0.95) in group A than group C. Among surgically confirmed AT cases only, mean time from admission to decision was shorter in group A than group B (2.6 vs. 4.6 hours, P = 0.014).Conclusions: We identified differences in time from admission to clinical decision and from admission to surgery among women with suspected AT during the COVID-19 pandemic.","PeriodicalId":50268,"journal":{"name":"Israel Medical Association Journal","volume":"26 7","pages":"405-409"},"PeriodicalIF":1.8,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141856961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Mucin Gene 5AC Expression in the Gastric Mucosa of Helicobacter pylori Positive Gastritis: A Systematic Review and Meta-analysis. 幽门螺杆菌阳性胃炎患者胃黏膜中黏蛋白基因 5AC 的表达：系统回顾与元分析》。

IF 1.8 4区医学

Israel Medical Association Journal Pub Date : 2024-08-01

Alexander N Kol-Yakov, Yaron Niv

引用次数: 0

Successful Management of a Dreaded Complication: Ventricular Septal Defect Following Late Arrival STEMI. 成功处理可怕的并发症：晚期 STEMI 后的室间隔缺损。

IF 1.8 4区医学

Israel Medical Association Journal Pub Date : 2024-06-01

Yuval Avidan, Amir Aker, Vsevolod Tabachnikov

引用次数: 0

A Novel Case of Continuous Electronic Urine Output Monitoring for De-escalation of Continuous Renal Replacement Therapy in Cardiac Intensive Care. 连续电子尿量监测用于心脏重症监护中连续肾脏替代疗法降级的新案例。

IF 1.8 4区医学

Israel Medical Association Journal Pub Date : 2024-06-01

Yacov Shacham

引用次数: 0

Clinical and Prognostic Features of Diabetic Ketoacidosis According to the Trigger of the Syndrome. 糖尿病酮症酸中毒的临床和预后特征与综合征的诱因有关。

IF 1.6 4区医学

Israel Medical Association Journal Pub Date : 2024-06-01

Ran Ben David, Iftach Sagy, Alan Jotkowitz, Leonid Barski

{"title":"Clinical and Prognostic Features of Diabetic Ketoacidosis According to the Trigger of the Syndrome.","authors":"Ran Ben David, Iftach Sagy, Alan Jotkowitz, Leonid Barski","doi":"","DOIUrl":"","url":null,"abstract":"Background: Diabetic ketoacidosis (DKA) is an acute metabolic, life-threatening complication of diabetes mellitus with a mortality rate that now stand at less than 1%. Although mortality is coupled with the etiology of DKA, literature on the influence of DKA etiology on patient outcome is scarce.Objectives: To study different triggers for DKA and their effect on outcomes.Methods: We conducted a retrospective study that include 385 DKA patients from 2004 to 2017. The study compared demographics, clinical presentation, and mortality rates by different precipitating factors.Results: Patients with DKA due to infections had a higher risk to develop in-hospital mortality after controlling for age and sex (odds ratio 4.40, 95% confidence interval 1.35-14.30), had a higher Charlson Comorbidity Index score, a higher risk of being mechanical ventilated (14% vs. 3%, P < 0.01), and a longer duration of hospitalization (5 days vs. 3 days, P < 0.001).Conclusions: It is crucial to find the triggers that precipitate DKA and start the treatment as early as possible in addition to the metabolic aspect of the treatment especially when the trigger is an infectious disease.","PeriodicalId":50268,"journal":{"name":"Israel Medical Association Journal","volume":"26 6","pages":"342-345"},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Hidradenitis Suppurativa Incidence and Prevalence Rates Are Increasing: A Population-based Study. 化脓性扁平湿疹的发病率和流行率正在上升：一项基于人群的研究

IF 1.6 4区医学

Israel Medical Association Journal Pub Date : 2024-06-01

Sharon Vanetik, Yochai Schonmann, Arnon D Cohen, Yuliya Valdman-Grinshpoun, Eran Shavit

{"title":"Hidradenitis Suppurativa Incidence and Prevalence Rates Are Increasing: A Population-based Study.","authors":"Sharon Vanetik, Yochai Schonmann, Arnon D Cohen, Yuliya Valdman-Grinshpoun, Eran Shavit","doi":"","DOIUrl":"","url":null,"abstract":"Background: Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease associated with a heavy burden of morbidity and cost.Objectives: To provide standardized estimates of trends in HS incidence and prevalence among patients in Israel between 2016 and 2019.Methods: We conducted a population-based analysis of routinely collected electronic health records data from Clalit Health Services, the largest nationwide public health service provider in Israel. Age- and sex-adjusted rates were reported by using the standard European population as a reference.Results: The study included 3488 HS incident cases. The mean ± SD age of onset was 30.3 years and was similar in males and females. HS was more common among Jews with low and medium socioeconomic status. The annual HS incidence rate increased throughout the study period. HS prevalence increased from 0.12% in 2016 to 0.17% in 2019.Conclusions: HS prevalence and incidence rates steadily rose among the Israeli population between 2016 and 2019. Awareness of these findings can help provide an optimal allocation of healthcare resources by policymakers and health service providers and prevent delays in diagnosis.","PeriodicalId":50268,"journal":{"name":"Israel Medical Association Journal","volume":"26 6","pages":"388-394"},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332347","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Pregnancy Outcomes in Women with Poorly Controlled Pregestational Diabetes Mellitus. 妊娠糖尿病控制不佳妇女的妊娠结局。

IF 1.6 4区医学

Israel Medical Association Journal Pub Date : 2024-06-01

Milana Gelman, Tzipora Galperin, Esther Maor-Sagie, Yochai Yoeli, Mordechai Hallak, Rinat Gabbay-Benziv, Amir Naeh

{"title":"Pregnancy Outcomes in Women with Poorly Controlled Pregestational Diabetes Mellitus.","authors":"Milana Gelman, Tzipora Galperin, Esther Maor-Sagie, Yochai Yoeli, Mordechai Hallak, Rinat Gabbay-Benziv, Amir Naeh","doi":"","DOIUrl":"","url":null,"abstract":"Background: The prevalence of pregestational diabetes mellitus (PGDM) in women of reproductive age has surged globally, contributing to increased rates of adverse pregnancy outcomes. Hemoglobin A1c (HbA1c) is a crucial marker for diagnosing and monitoring PGDM, with periconceptional levels influencing the risk of congenital anomalies and complications.Objectives: To evaluate the association between periconceptional HbA1c levels and perinatal complications in pregnant women with poorly controlled PGDM.Methods: We conducted a retrospective analysis of prospectively collected data of pregnancies between 2010 and 2019, HbA1c > 6% at 3 months prior to conception or during the first trimester. Outcomes of periconceptional HbA1c levels were compared.Results: The cohort included 89 women: 49 with HbA1c 6-8%, 29 with HbA1c 8-10%, and 11 with HbA1c > 10%. Higher HbA1c levels were more prevalent in type 1 diabetics and were associated with increased end-organ damage risk. Women with elevated HbA1c levels tended toward unbalanced glucose levels during pregnancy. The cohort exhibited high rates of preterm delivery, hypertensive disorders, cesarean delivery, and neonatal intensive care unit admission. Overall live birth rate was 83%. While a significant correlation was found between HbA1c levels and preterm delivery, no consistent association was observed with other adverse outcomes.Conclusions: Periconceptional glycemic control in PGDM pregnancies is important. Elevated HbA1c levels are associated with increased risks of adverse outcomes. Beyond a certain HbA1c level, risks of complications may not proportionally escalate.","PeriodicalId":50268,"journal":{"name":"Israel Medical Association Journal","volume":"26 6","pages":"376-382"},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Diagnostic and Therapeutic Yield of Imaging Studies in Patients with Dementia and Gram-negative Bloodstream Infections: A Retrospective Cohort Study. 痴呆症和革兰氏阴性血流感染患者的影像学诊断和治疗效果：一项回顾性队列研究

IF 1.6 4区医学

Israel Medical Association Journal Pub Date : 2024-06-01

Mahmoud Massalha, Sharon Reisfeld

{"title":"Diagnostic and Therapeutic Yield of Imaging Studies in Patients with Dementia and Gram-negative Bloodstream Infections: A Retrospective Cohort Study.","authors":"Mahmoud Massalha, Sharon Reisfeld","doi":"","DOIUrl":"","url":null,"abstract":"Background: Gram-negative bloodstream infections (GN-BSI) are life threatening. Appropriate antimicrobial therapy and source control when indicated improve survival. Dementia is an independent risk factor for death and is associated with increased risk for infections, especially in advanced stages. Data about the best diagnostic and therapeutic approaches for patients with dementia and GN-BSI are lacking.Objectives: To evaluate patients with dementia and GN-BSI and determine whether diagnostic imaging improves clinical outcomes.Methods: We performed a retrospective cohort study of adult patients with GN-BSI, during 2019-2022. Patients with or without a diagnosis of dementia were compared. Outcomes were in-hospital mortality and recurrent bacteremia. Demographic, clinical, diagnostic, and therapeutic data were collected and analyzed.Results: A total of 87 patients with dementia and 130 without were included. Patients with dementia received appropriate empirical antimicrobial therapy in 38% of cases compared to 62% of patients without dementia, P < 0.001. Imaging studies were performed in half of patients in both groups. In the dementia group, 17% had abnormal findings that required source control versus 30% in the control group (P = 0.049). Source control was performed in 15% of patients with dementia versus 28% of patients without dementia (P = 0.032). Mortality was 27.6% in the dementia group versus 22.3% in the control group (P = 0.42).Conclusions: In patients with dementia and GN-BSI, imaging studies have lower effect on clinical outcomes. Imaging studies should be performed in selected cases only and not conducted routinely.","PeriodicalId":50268,"journal":{"name":"Israel Medical Association Journal","volume":"26 6","pages":"383-387"},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Intra-articular Knee Injection Is Less Painful Than Expected. 膝关节腔内注射的疼痛比预期轻

IF 1.6 4区医学

Israel Medical Association Journal Pub Date : 2024-06-01

Assaf Albagli, Ehud Rath, Matias Vidra, David Ben Haroush, Shai Factor, Eyal Amar

{"title":"Intra-articular Knee Injection Is Less Painful Than Expected.","authors":"Assaf Albagli, Ehud Rath, Matias Vidra, David Ben Haroush, Shai Factor, Eyal Amar","doi":"","DOIUrl":"","url":null,"abstract":"Background: Intra-articular knee injections (IAKI) are commonly used for diagnostic and therapeutic purposes but may induce anxiety and fear. While existing literature has identified the variance between expected and actual pain levels in various medical procedures, this phenomenon remains unexplored in the context of IAKI.Objectives: To describe the differences between anticipated and experienced pain recorded during IAKI.Methods: The study cohort included 50 patients who underwent IAKI by an orthopedic specialist in an outpatient clinic. Patients recruited to the study recorded the anticipated and experienced pain, anxiety index, and factors influencing injection related fear.Results: The study population (n=50) demonstrated a significant difference between the pain expected before the injection (mean Visual Analogue Scale [VAS] score 6.19) and the actual experienced (mean VAS score 2.07, P-value < 0.001). Significant differences between anticipated and experienced VAS scores were demonstrated for both females and males. There was a significant difference between males and females in terms of estimated VAS score. There was no significant difference between males and females in term of the experienced VAS score. The difference (delta) between expected and experienced pain differed significantly between sexes.Conclusions: These findings emphasize the importance of educating patients about expected pain levels during IAKI. Presenting this quantified information may reassure patients that the procedure is not as painful as expected, which can potentially increase the compliance.","PeriodicalId":50268,"journal":{"name":"Israel Medical Association Journal","volume":"26 6","pages":"346-350"},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Establishing a New Left Ventricular Assist Device Program: From Concept to Reality. 建立新的左心室辅助设备计划：从概念到现实。

IF 1.6 4区医学

Israel Medical Association Journal Pub Date : 2024-06-01

Ehud Jacobzon, Avital Lifschitz, Danny Fink, Tal Hasin

{"title":"Establishing a New Left Ventricular Assist Device Program: From Concept to Reality.","authors":"Ehud Jacobzon, Avital Lifschitz, Danny Fink, Tal Hasin","doi":"","DOIUrl":"","url":null,"abstract":"Background: Left ventricular assist devices (LVAD) are a staple element in contemporary treatment of advanced heart failure. LVAD surgeries are mostly done in heart transplantations centers, as a destination therapy or as a bridge to heart transplantation.Objectives: To describe our step-by-step experience in establishing and implementing a new LVAD program in a non-heart transplant center. To give insight to our short- and long-term results of our first 25 LVAD patients.Methods: Preliminary steps included identifying the need for a new program and establishing the leading team. Next is defining protocols for pre-operative evaluation, operating room, post-operative management, and outpatient follow-up. The leading team needs to educate other relevant units in the hospital that will be involved in the care of these patients. It is essential to work in collaboration with a heart transplant center from the very beginning. Patient selection is of major importance especially in the early experience. Initially \"low risk\" patients should be enrolled.Results: We describe our first 25 LVAD patients. Our first five patients all survived beyond 2 years, with no major complications. Overall, there was one operative death due to massive GI bleeding. There were four late deaths due to septic events.Conclusions: Establishing a new LVAD program can be successful also with small- and medium-size programs. With careful and meticulous planning LVAD implantation can be extended to more centers thus offering an excellent solution for advanced heart failure patients.","PeriodicalId":50268,"journal":{"name":"Israel Medical Association Journal","volume":"26 6","pages":"351-354"},"PeriodicalIF":1.6,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141332345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0